- Recent Funding
- Investors
- Bain Capital Life Sciences
Bain Capital Life Sciences portfolio
Bain Capital Life Sciences has 11 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.
About this page
It is a venture capital firm based in Boston, US, founded in 2016. It led 6 of the 9 rounds it joined. Its most recent investment on record is Seran Bioscience's Series B+ round in September 2026, alongside Biospring Partners and Vivo Capital. By category, its portfolio leans toward Health and bio (11) and Manufacturing and industrial (2). It has co-invested with GV, Third Rock Ventures and RA Capital Management, most often GV (3 rounds).
About Bain Capital Life Sciences
Fund returns
| Fund | Vintage | Size | Net IRR | TVPI | DPI | As of |
|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Fund IV. L.P. | 2024 | — | — | 0.00x | 0.00x | Jun 30, 2025 |
What Bain Capital Life Sciences invests in
- Health and bio · 11 · 100%
- Manufacturing and industrial · 2 · 18%
- Logistics and mobility · 1 · 9%
- Education · 1 · 9%
Bain Capital Life Sciences recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ | Biospring Partners (lead), Vivo Capital | ||
| Series B+ · $315M | Fidelity Management & Research Company, Morningside, Eli Lilly +15 | ||
| Series A · $165M | Dexcel Pharma (lead), Third Rock Ventures (lead), Pictet Private Equity Investors S.A. +2 | ||
| Series A · $120M · lead | Third Rock Ventures (lead), Biotechnology Value Fund (lead), Perceptive Advisors +1 | ||
| Series B+ · lead | Janus Henderson Investors, Elikon Venture, OrbiMed +3 | ||
| Series A · $75M · lead | Access Biotechnology, Viking Global Investors, Maverick Capital +6 | ||
| Series A · $245M · lead | Forbion Capital Partners (lead), Atlas Venture (lead), RA Capital Management +1 | ||
| Series B+ · $107M · lead | AbbVie, Avalon Ventures, Pfizer Venture Investments +3 |
How Bain Capital Life Sciences invests
Bain Capital Life Sciences portfolio companies
SSeran BioscienceSeries B+ · Sep 2026
AAdvanCell$315MSeries B+ · Jul 2026
SSyremis Therapeutics$165MSeries A · Dec 2025
MMerida Biosciences$120MSeries A · May 2025
AAngitia BioSeries B+ · Dec 2024
AAreteia Therapeutics$75MSeries A · Feb 2024
AAiolos Bio$245MSeries A · Nov 2023
JJnana Therapeutics$107MSeries B+ · Nov 2022
EEmalex Biosciences$250MSeries B+ · Nov 2022
OOMass Therapeuticsbacker
CCardurion Pharmaceuticalsbacker
| Company | Round with Bain Capital Life Sciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ | undisclosed | Sep 29, 2026 Series B+ |
Health and bio |
Series B+ · $315M | $439.5M | Jul 15, 2026 Series B+ |
Health and bio |
Series A · $165M | $165M | Dec 18, 2025 Series A |
Health and bio |
Series A · $120M · lead | $120M | May 7, 2025 Series A |
Health and bio |
Series B+ · lead | $130M | Feb 12, 2026 Series B+ |
Health and bio |
Series A · $75M · lead | $75M | Feb 13, 2024 Series A |
Health and bio |
Series A · $245M · lead | $245M | Nov 20, 2023 Series A |
Health and bio |
Series B+ · $107M · lead | $207M | Nov 15, 2022 Series B+ |
Health and bio |
Series B+ · $250M · lead | $285M | Nov 3, 2022 Series B+ |
Health and bio |
backer | $422.51M | Oct 15, 2026 Series B+ |
Health and bio |
backer | $260M | Jul 16, 2024 Series B+ |
Most frequent co-investors
GGV3 shared rounds · last Dec 18, 2025
TThird Rock Ventures2 shared rounds · last Dec 18, 2025
RRA Capital Management2 shared rounds · last Nov 20, 2023
BBiospring Partners1 shared round · last Sep 29, 2026
VVivo Capital1 shared round · last Sep 29, 2026
TT. Rowe Price1 shared round · last Jul 15, 2026
EEli Lilly1 shared round · last Jul 15, 2026
SSanofi Ventures1 shared round · last Jul 15, 2026
MMorningside1 shared round · last Jul 15, 2026
AAbingworth1 shared round · last Jul 15, 2026
SSymBiosis1 shared round · last Jul 15, 2026
BBrandon Capital1 shared round · last Jul 15, 2026
Similar investors
DDecheng Capital11 companies · 6 deals in 12 mo
LLightbank11 companies · 6 deals in 12 mo
HHillhouse Investment11 companies · 4 deals in 12 mo
PPlus Capital11 companies · 4 deals in 12 mo
SS3 Ventures11 companies · 4 deals in 12 mo
SSixty Degree Capital11 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Net returns as reported by the public-pension and foundation LPs invested in each fund.
Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 9 rounds on Recent Funding that name Bain Capital Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Bain Capital Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/bain-capital-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy